Skip to main content
. 2018 Jul 10;6:186. doi: 10.3389/fpubh.2018.00186

Figure 2.

Figure 2

The incidence of CHIKV IgM+ patients and the reported incidence of arthralgia and neurological symptoms of a 27 month period.